Especialista en Cardiología.
Centro Médico ABC.
Cédula profesional: 1045529.
Ampudia-Blasco FJ, et al. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents. J Diabetes Complications. 2021 Mar;35(3):107828.
Marx N, et al. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation. 2022 Dec 13;146(24):1882-1894.
Andreozzi F, et al. Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review. Diabetol Metab Syndr. 2020 Jun 17;12:52.
Nauck MA, et al. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Circulation. 2017 Aug 29;136(9):849-870.